About the hybrid catalyst TioTio® PREMIUM
Antiviral testing using the new coronavirus (SARS-CoV-2)
As a result of testing by a public testing agency, the number of novel coronaviruses on the product was
It was confirmed that it reduced the amount by more than 99.9%.
Announced by the manufacturers of TioTio® PREMIUM.
*From a news release from Sunward Shokai Co., Ltd.